HomeAVBP • NASDAQ
add
Arrivent Biopharma Inc
Previous close
$20.10
Day range
$19.20 - $20.40
Year range
$14.35 - $25.95
Market cap
655.81M USD
Avg Volume
105.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 20.67M | 69.85% |
Net income | -17.42M | -43.09% |
Net profit margin | — | — |
Earnings per share | -0.70 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 317.39M | 94.28% |
Total assets | 327.84M | — |
Total liabilities | 10.12M | — |
Total equity | 317.72M | — |
Shares outstanding | 33.49M | — |
Price to book | 2.12 | — |
Return on assets | -21.06% | — |
Return on capital | -22.01% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -17.42M | -43.09% |
Cash from operations | -18.63M | -10.35% |
Cash from investing | — | — |
Cash from financing | 185.63M | 312.80% |
Net change in cash | 167.00M | 494.57% |
Free cash flow | -14.46M | — |
About
Founded
2021
Headquarters
Website
Employees
40